Sabinsa has developed a new product sourced from turmeric, yet another innovation stemming from their deep research into that revered root. CurCousin™, Sabinsa’s latest branded ingredient, contains Calebin A, a curcumin analog naturally present in Curcuma longa and Curcuma caesia.

CurCousin helps balance cholesterol and support healthy blood sugar levels and circulation. It also supports a healthy body weight by inhibiting adipogenesis (fat cells). The product is clinically studied with a dosage of 25 mg twice a day. Sabinsa holds 65 US and international patents on this product, which has self-affirmed GRAS status.


A published study led by Sabinsa chairman and founder Dr. Muhammed Majeed evaluated the clinical efficacy and safety of Calebin A in managing weight in 40 obese or overweight individuals for 90 days. The subjects were administered Calebin A capsules (25 mg, one capsule twice a day). Significant reduction in body weight and body mass index were observed in the Calebin A group compared with placebo after 90 days. Additionally, a significant change in serum biomarkers like leptin, adiponectin, and cortisol was observed in the study subjects, with improved blood lipid profiles. Moreover, Calebin A was found to be safe and well-tolerated by all the subjects (1). The clinical study showed that Calebin A is effective in managing healthy body weight by inhibiting adipogenesis and is an ideal candidate to support metabolic health.

“Deep knowledge of curcumin has been a passion of our research teams for many years, and has resulted in industry leading ingredients like Curcumin C3 Complex,” said Dr Majeed. “We’re enthusiastic about the potential of CurCousin and eager to share details about it with our customers across the world.”

1.        Majeed et al., International Journal of Ayurveda and Pharma Research, 4(11): 10-17 (2016)